Lyn Kinase-Dependent Regulation of miR181 and Myeloid Cell Leukemia-1 Expression: Implications for Drug Resistance in Myelogenous Leukemia
Eric I. Zimmerman, Lee M. Graves(University of North Carolina at Chapel Hill)
Cited by 74
Related Papers
Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia
|PLoS ONE|2013|73
Mass spectrometry–based selectivity profiling identifies a highly selective inhibitor of the kinase MELK that delays mitotic entry in cancer cells
|Journal of Biological Chemistry|2020|30
Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer
|Frontiers in Pharmacology|2023|20
BIRC6 mediates imatinib resistance independently of Mcl-1
|PLoS ONE|2017|19